Alaven Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Alaven Pharmaceuticals Ownership

Who owns Alaven Pharmaceuticals?

Alaven Pharmaceuticals is owned by Meda AB. It was acquired on October 5, 2010.

Was Alaven Pharmaceuticals formerly PE-backed?

Yes. Alaven Pharmaceuticals was formerly owned by 2 private investors.

Alaven Pharmaceuticals Business Overview

Where is Alaven Pharmaceuticals headquartered?

Alaven Pharmaceuticals is headquartered in Marietta, Georgia.

What sector is Alaven Pharmaceuticals in?

Alaven Pharmaceuticals is a life science company.

When was Alaven Pharmaceuticals founded?

Alaven Pharmaceuticals was founded in 2003.

Life Science M&A Summary in 2010

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2010. The largest life science acquisition in 2010 was Solvay Pharmaceuticals - which was acquired by Abbott Laboratories for $6.1B.

Join Mergr to view all 138 acquisitions of life science companies in 2010, including 15 acquisitions by private equity firms, and 123 by strategics.

Alaven Pharmaceuticals LLC

200 North Cobb Parkway Building 400, Suite 428,
Marietta, Georgia 30062
United States,
(678) 589-7000

Alaven Pharmaceutical LLC is a specialty pharmaceutical company, develops and markets prescription and non-prescription products that treat women’s health, gastroenterology, and anemia conditions in the United States.


 Subscribe to unlock this and 208,151
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.